• BUSINESS
    • FINANCE
    • LEGAL
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • HEALTHCARE & PHARMACEUTICALS
    • MEDIA & TELECOM
    • AEROSPACE AND DEFENSE
    • ENERGY
  • MARKETS
    • EUROPEAN MARKETS
    • ASIAN MARKETS
    • U.S. MARKETS
    • COMMODITIES
    • EMERGING MARKETS
    • DEALS
    • RATES & BONDS
  • WORLD
    • UNITED STATES
    • EUROPE
    • UNITED KINGDOM
    • ASIA PACIFIC
    • MIDDLE EAST
    • AFRICA
    • CHINA
    • INDIA
    • JAPAN
    • AMERICAS
    • FRANCE
    • GERMANY
  • POLITICS
    • GOVERNMENT
    • UNITED STATES
    • US SUPREME COURT
  • TECH
    • ARTIFICIAL INTELLIGENCE
    • CYBERSECURITY
    • SPACE
    • DISRUPTED
  • COMMENTARY
  • BREAKINGVIEWS
    • BREAKINGVIEWS PREDICTIONS
  • MONEY
    • WEALTH
    • FUNDS
    • ETFS
  • LIFE
    • LIFESTYLE
    • SPORTS
    • SCIENCE
  • SECTORS
    • ENERGY
    • HEALTHCARE
    • MEDIA & TELECOM
    • SUSTAINABILITY
    • ENVIRONMENT
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • AEROSPACE AND DEFENSE
FinanceTime
  • August 20th, 2026

FinanceTimeFinancetime

  • BUSINESS
    • FINANCE
    • LEGAL
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • HEALTHCARE & PHARMACEUTICALS
    • MEDIA & TELECOM
    • AEROSPACE AND DEFENSE
    • ENERGY
  • MARKETS
    • EUROPEAN MARKETS
    • ASIAN MARKETS
    • U.S. MARKETS
    • COMMODITIES
    • EMERGING MARKETS
    • DEALS
    • RATES & BONDS
  • WORLD
    • UNITED STATES
    • EUROPE
    • UNITED KINGDOM
    • ASIA PACIFIC
    • MIDDLE EAST
    • AFRICA
    • CHINA
    • INDIA
    • JAPAN
    • AMERICAS
    • FRANCE
    • GERMANY
  • POLITICS
    • GOVERNMENT
    • UNITED STATES
    • US SUPREME COURT
  • TECH
    • ARTIFICIAL INTELLIGENCE
    • CYBERSECURITY
    • SPACE
    • DISRUPTED
  • COMMENTARY
  • BREAKINGVIEWS
    • BREAKINGVIEWS PREDICTIONS
  • MONEY
    • WEALTH
    • FUNDS
    • ETFS
  • LIFE
    • LIFESTYLE
    • SPORTS
    • SCIENCE
  • SECTORS
    • ENERGY
    • HEALTHCARE
    • MEDIA & TELECOM
    • SUSTAINABILITY
    • ENVIRONMENT
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • AEROSPACE AND DEFENSE
Home
Business
Healthcare & Pharmaceuticals

Galderma's net sales top $4 billion in 2023 ahead of potential IPO

February 29th, 2024 | 05:11 AM BUSINESS Healthcare & Pharmaceuticals 2

Facebook Twitter Google+ LinkedIn Pinterest

Worth reading...

Michigan cyclosporiasis cases rise by 368 in a week to 14,277
India's Manipal Health sees adjusted quarterly profit jump on strong demand for complex care
Congo set to receive 70,000 Ervebo vaccines to contain Ebola outbreak, WHO says
Green giant: How Taylor Farms became a top salad supplier before US diarrhea outbreak
By Emma-Victoria Farr

Swiss dermatology company Galderma on Thursday said it generated more than $4 billion in net sales during 2023, up 8.5% on 2022 on a constant currency basis, driven by momentum across its dermatological skincare and injectable aesthetics products.

The results come ahead of a possible initial public offering (IPO), as Galderma is among a handful of companies considering going public on Europe's stock exchanges in the first half of the year if market conditions allow, as reported by Reuters.

Galderma, backed by private equity firm EQT (EQTAB.ST), is preparing to kick off an IPO as soon as next month, as reported.

The company started preparing for an IPO more than two years ago, but had to postpone plans due to challenging equity markets.

If it goes ahead, the IPO could be one of the biggest in Europe in 2024, valuing the company at around $20 billion, sources have said.

Rising momentum for deals comes as central banks have started signalling an end to interest rate rises in a boost for equity markets.

Galderma said it achieved core EBITDA (earnings before interest, taxes, depreciation, and amortisation) for 2023 of $942 million, with 21.4% year-on-year growth on a constant currency basis.

"This has been a landmark year for Galderma, underscoring the strong momentum and sustained growth we have seen over the past four years," Chief Executive Flemming Ornskov said.

"We expect this momentum to continue in 2024 and beyond," he added. In 2024, Galderma expects to deliver 7-10% net sales growth on a constant currency basis.

Founded in 1981, Galderma was carved out of Nestlé (NESN.S) in 2019 and bought for 10.2 billion Swiss francs ($11.60 billion) by a consortium led by EQT, including Singapore's GIC and the Abu Dhabi Investment Authority.

"Galderma is run like a public company and we are prepared for the next step," Ornskov said in an interview with Reuters last year.

EQT earlier this week announced that it had raised 22 billion euros ($23.84 billion) for its latest buyout fund, its largest-ever fundraising, despite a challenging environment.

($1 = 0.8796 Swiss francs)

($1 = 0.9228 euros)

  • Topic
  • RESULTS/IPO
  • GALDERMA
Facebook Twitter Google+ LinkedIn Pinterest
Previous article Michigan cyclosporiasis cases rise by 368 in a week to 14,277

Related Posts

Healthcare & Pharmaceuticals
August 20th, 2026

Michigan cyclosporiasis cases rise by 368 in a week to 14,277

Healthcare & Pharmaceuticals
August 20th, 2026

India's Manipal Health sees adjusted quarterly profit jump on strong dem...

Healthcare & Pharmaceuticals
August 20th, 2026

Congo set to receive 70,000 Ervebo vaccines to contain Ebola outbreak, W...

Healthcare & Pharmaceuticals
August 20th, 2026

Green giant: How Taylor Farms became a top salad supplier before US diar...

Healthcare & Pharmaceuticals
August 20th, 2026

Congo's M23 rebels introduce new movement restrictions over Ebola concer...

Healthcare & Pharmaceuticals
August 20th, 2026

First screwworm case detected in Mexican state of Sonora

The Wire
Aug 20th 2 h ago
Asia Pacific

UN says two staff members detained in Afghanistan have been...

Aug 20th 2 h ago
Business

US Treasury buyback briefly eases bond rout, but debt worri...

Aug 20th 2 h ago
Middle East

U.S. targets Hezbollah with fresh sanctions, emphasizes tie...

Aug 20th 2 h ago
China

Nvidia to ship AI chip for China by year-end, The Informati...

Aug 20th 2 h ago
Africa

Cameroon president returns home after 10-week absence

TRENDING ON FINANCETIME
Aug 20th, 2026 Government

FBI raids Democrat Swalwell's home in sexual-misconduct investigation, source says

Aug 20th, 2026 Europe

Ousted Ukrainian defence minister's gamble against Zelenskiy backfires as protests end

Aug 20th, 2026 World

US Justice Department opposes immediate hearing in Disney ABC license lawsuit

Aug 20th, 2026 World

Academic who raised plagiarism allegations against Jason Arday suspended by his university

Aug 20th, 2026 Healthcare & Pharmaceuticals

Michigan cyclosporiasis cases rise by 368 in a week to 14,277

Markets-Sectors
TELECOMMUNICATIONS SERVICES +0.03%

  • BUSINESS
  • MARKETS
  • WORLD
  • POLITICS
  • TECH
  • COMMENTARY
  • BREAKINGVIEWS
  • MONEY
  • LIFE
  • SECTORS
  • Back to top
FinanceTime
FinanceTime

World Business & Financial News, Breaking US & International News

Additional Services
  • Privacy-Policy
  • Terms and Conditions
© Financetime.org 2026. All rights reserved. Hosted by LeadsDeposit.com
Produced by C-iT